Haemophilus B and hepatitis B vaccine

Last updated

Haemophilus B and hepatitis B vaccine
Combination of
Hib vaccine Vaccine
Hepatitis B vaccine Vaccine
Clinical data
Trade names Comvax
AHFS/Drugs.com Micromedex Detailed Consumer Information
Routes of
administration 		Intramuscular
ATC code
Identifiers
CAS Number
ChemSpider
  • none

Haemophilus B and hepatitis B vaccine is a combination vaccine whose generic name is Haemophilus b conjugate and hepatitis B recombinant vaccine. [1] [2] It protects against the infectious diseases Haemophilus influenzae type B and hepatitis B. [2]

A branded formulation, Comvax, was marketed in the US by Merck. [3] [4] It was discontinued in 2014. [5]

References

  1. ↑ "Comvax". Drugs.com. Archived from the original on 16 June 2024. Retrieved 15 July 2018.
  2. 1 2 "Haemophilus b conjugate and hepatitis b vaccine Intramuscular Advanced Patient Information". Drugs.com. 14 February 2020. Retrieved 13 September 2020.
  3. ↑ Centers for Disease Control and Prevention (February 1997). "FDA approval for infants of a Haemophilus influenzae type b conjugate and hepatitis B (recombinant) combined vaccine" (PDF). MMWR Morb. Mortal. Wkly. Rep. 46 (5): 107–9. PMID   9045037.
  4. ↑ "Comvax package insert" (PDF). Retrieved 15 July 2018.
  5. ↑ Zarei AE, Almehdar HA, Redwan EM (2016). "Hib Vaccines: Past, Present, and Future Perspectives". Journal of Immunology Research. 2016 7203587. doi: 10.1155/2016/7203587 . PMC   4745871 . PMID   26904695.
Syringe with Green Fluid.jpg

This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.